Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Sionna Therapeutics Inc.

Clinical trials sponsored by Sionna Therapeutics Inc., explained in plain language.

Sionna Therapeutics, Inc. SION NASDAQ

A biotech developing treatments for cystic fibrosis.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New CF drug cocktail enters first human safety tests

Disease control Recruiting now

This early-stage trial tests the safety of three experimental drugs (SION-451, SION-2222, and SION-109) given together to healthy adults aged 18–55. The study aims to see if the combinations are safe and how the body processes them. It is a first step toward possibly developing a…

Phase: PHASE1 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control

Last updated Jun 26, 2026 13:20 UTC